Clinical trial
Evaluating the Efficacy and Safety of Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
NCT05543343 is registered in ClinicalTrials.gov with Qu Yiqing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Efficacy and Safety of Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
- Lead sponsor
- Qu Yiqing
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 5, 2022
- Completion date
- August 31, 2023
- Enrollment
- 495 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.